210 related articles for article (PubMed ID: 34864677)
1. 5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease.
Chen L; Shen Q; Xu S; Yu H; Pei S; Zhang Y; He X; Wang Q; Li D
J Alzheimers Dis; 2022; 85(2):573-585. PubMed ID: 34864677
[TBL] [Abstract][Full Text] [Related]
2. 5-Hydroxymethylcytosine signature in circulating cell-free DNA as a potential diagnostic factor for early-stage colorectal cancer and precancerous adenoma.
Xiao Z; Wu W; Wu C; Li M; Sun F; Zheng L; Liu G; Li X; Yun Z; Tang J; Yu Y; Luo S; Sun W; Feng X; Cheng Q; Tao X; Wu S; Tao J
Mol Oncol; 2021 Jan; 15(1):138-150. PubMed ID: 33107199
[TBL] [Abstract][Full Text] [Related]
3. Genome-Wide Mapping Implicates 5-Hydroxymethylcytosines in Diabetes Mellitus and Alzheimer's Disease.
Beadell AV; Zhang Z; Capuano AW; Bennett DA; He C; Zhang W; Arvanitakis Z
J Alzheimers Dis; 2023; 93(3):1135-1151. PubMed ID: 37182870
[TBL] [Abstract][Full Text] [Related]
4. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic and predictive biomarkers for coronary artery disease.
Dong C; Chen J; Zheng J; Liang Y; Yu T; Liu Y; Gao F; Long J; Chen H; Zhu Q; He Z; Hu S; He C; Lin J; Tang Y; Zhu H
Clin Epigenetics; 2020 Jan; 12(1):17. PubMed ID: 31964422
[TBL] [Abstract][Full Text] [Related]
5. 5-Hydroxymethylcytosine profiling from genomic and cell-free DNA for colorectal cancers patients.
Gao P; Lin S; Cai M; Zhu Y; Song Y; Sui Y; Lin J; Liu J; Lu X; Zhong Y; Cui Y; Zhou P
J Cell Mol Med; 2019 May; 23(5):3530-3537. PubMed ID: 30912288
[TBL] [Abstract][Full Text] [Related]
6. Ethnicity-specific and overlapping alterations of brain hydroxymethylome in Alzheimer's disease.
Qin L; Xu Q; Li Z; Chen L; Li Y; Yang N; Liu Z; Guo J; Shen L; Allen EG; Chen C; Ma C; Wu H; Zhu X; Jin P; Tang B
Hum Mol Genet; 2020 Jan; 29(1):149-158. PubMed ID: 31814020
[TBL] [Abstract][Full Text] [Related]
7. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers.
Li W; Zhang X; Lu X; You L; Song Y; Luo Z; Zhang J; Nie J; Zheng W; Xu D; Wang Y; Dong Y; Yu S; Hong J; Shi J; Hao H; Luo F; Hua L; Wang P; Qian X; Yuan F; Wei L; Cui M; Zhang T; Liao Q; Dai M; Liu Z; Chen G; Meckel K; Adhikari S; Jia G; Bissonnette MB; Zhang X; Zhao Y; Zhang W; He C; Liu J
Cell Res; 2017 Oct; 27(10):1243-1257. PubMed ID: 28925386
[TBL] [Abstract][Full Text] [Related]
8. Identification of fetal unmodified and 5-hydroxymethylated CG sites in maternal cell-free DNA for non-invasive prenatal testing.
Gordevičius J; Narmontė M; Gibas P; Kvederavičiūtė K; Tomkutė V; Paluoja P; Krjutškov K; Salumets A; Kriukienė E
Clin Epigenetics; 2020 Oct; 12(1):153. PubMed ID: 33081811
[TBL] [Abstract][Full Text] [Related]
9. 5-Hydroxymethylation-associated epigenetic modifiers of Alzheimer's disease modulate Tau-induced neurotoxicity.
Bernstein AI; Lin Y; Street RC; Lin L; Dai Q; Yu L; Bao H; Gearing M; Lah JJ; Nelson PT; He C; Levey AI; Mullé JG; Duan R; Jin P
Hum Mol Genet; 2016 Jun; 25(12):2437-2450. PubMed ID: 27060332
[TBL] [Abstract][Full Text] [Related]
10. Liquid biopsy by combining 5-hydroxymethylcytosine signatures of plasma cell-free DNA and protein biomarkers for diagnosis and prognosis of hepatocellular carcinoma.
Cai Z; Zhang J; He Y; Xia L; Dong X; Chen G; Zhou Y; Hu X; Zhong S; Wang Y; Chen H; Xie D; Liu X; Liu J
ESMO Open; 2021 Feb; 6(1):100021. PubMed ID: 33508734
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide alteration of 5-hydroxymenthylcytosine in a mouse model of Alzheimer's disease.
Shu L; Sun W; Li L; Xu Z; Lin L; Xie P; Shen H; Huang L; Xu Q; Jin P; Li X
BMC Genomics; 2016 May; 17():381. PubMed ID: 27207465
[TBL] [Abstract][Full Text] [Related]
12. Neurofilament-labeled pyramidal neurons and astrocytes are deficient in DNA methylation marks in Alzheimer's disease.
Phipps AJ; Vickers JC; Taberlay PC; Woodhouse A
Neurobiol Aging; 2016 Sep; 45():30-42. PubMed ID: 27459923
[TBL] [Abstract][Full Text] [Related]
13. 5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages.
Song CX; Yin S; Ma L; Wheeler A; Chen Y; Zhang Y; Liu B; Xiong J; Zhang W; Hu J; Zhou Z; Dong B; Tian Z; Jeffrey SS; Chua MS; So S; Li W; Wei Y; Diao J; Xie D; Quake SR
Cell Res; 2017 Oct; 27(10):1231-1242. PubMed ID: 28820176
[TBL] [Abstract][Full Text] [Related]
14. Alterations of 5-hydroxymethylcytosines in circulating cell-free DNA reflect retinopathy in type 2 diabetes.
Han L; Chen C; Lu X; Song Y; Zhang Z; Zeng C; Chiu R; Li L; Xu M; He C; Zhang W; Duan S
Genomics; 2021 Jan; 113(1 Pt 1):79-87. PubMed ID: 33221518
[TBL] [Abstract][Full Text] [Related]
15. Global changes in DNA methylation and hydroxymethylation in Alzheimer's disease human brain.
Coppieters N; Dieriks BV; Lill C; Faull RL; Curtis MA; Dragunow M
Neurobiol Aging; 2014 Jun; 35(6):1334-44. PubMed ID: 24387984
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's Precision Neurology: Epigenetics of Cytochrome P450 Genes in Circulating Cell-Free DNA for Disease Prediction and Mechanism.
Bahado-Singh RO; Vishweswaraiah S; Turkoglu O; Graham SF; Radhakrishna U
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769199
[TBL] [Abstract][Full Text] [Related]
17. Altered 5-Hydroxymethylcytosine Landscape in Primary Gastric Adenocarcinoma.
Liu H; Xu T; Cheng Y; Jin MH; Chang MY; Shu Q; Allen EG; Jin P; Wang X
DNA Cell Biol; 2019 Dec; 38(12):1460-1469. PubMed ID: 31657619
[TBL] [Abstract][Full Text] [Related]
18. Single-Base Resolution Mapping of 5-Hydroxymethylcytosine Modifications in Hippocampus of Alzheimer's Disease Subjects.
Ellison EM; Bradley-Whitman MA; Lovell MA
J Mol Neurosci; 2017 Oct; 63(2):185-197. PubMed ID: 28866733
[TBL] [Abstract][Full Text] [Related]
19. Cell-free DNA 5-hydroxymethylcytosine is an emerging marker of acute myeloid leukemia.
Shao J; Wang S; West-Szymanski D; Karpus J; Shah S; Ganguly S; Smith J; Zu Y; He C; Li Z
Sci Rep; 2022 Jul; 12(1):12410. PubMed ID: 35859008
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma.
Chiu BC; Zhang Z; You Q; Zeng C; Stepniak E; Bracci PM; Yu K; Venkataraman G; Smith SM; He C; Zhang W
Blood Adv; 2019 Oct; 3(19):2790-2799. PubMed ID: 31570490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
